129 - Age at Diagnosis, Glycemic Control and Responses to Oral Blood Glucose Lowering Drugs in Type 2 Diabetes: A Population-Based Study

2019 ◽  
Vol 43 (7) ◽  
pp. S44
Author(s):  
Calvin Ke ◽  
Therese A. Stukel ◽  
Baiju R. Shah ◽  
Eric Lau ◽  
Ronald C.W. Mawing-Yee So ◽  
...  
Diabetologia ◽  
2014 ◽  
Vol 57 (8) ◽  
pp. 1586-1594 ◽  
Author(s):  
Marcus Lind ◽  
Aldina Pivodic ◽  
Lucia Cea-Soriano ◽  
Olle Nerman ◽  
Nils-Gunnar Pehrsson ◽  
...  

PLoS Medicine ◽  
2020 ◽  
Vol 17 (9) ◽  
pp. e1003316
Author(s):  
Calvin Ke ◽  
Thérèse A. Stukel ◽  
Baiju R. Shah ◽  
Eric Lau ◽  
Ronald C. Ma ◽  
...  

2007 ◽  
Vol 17 (3) ◽  
pp. 291-296 ◽  
Author(s):  
A. Hussain ◽  
S. Vaaler ◽  
M. A. Sayeed ◽  
H. Mahtab ◽  
S. M. K. Ali ◽  
...  

2018 ◽  
Vol 143 ◽  
pp. 398-408 ◽  
Author(s):  
Massimo Vicentini ◽  
Paola Ballotari ◽  
Paolo Giorgi Rossi ◽  
Francesco Venturelli ◽  
Claudio Sacchettini ◽  
...  

2017 ◽  
Vol 188 ◽  
pp. 173-180.e1 ◽  
Author(s):  
Joseph Meyerovitch ◽  
Maya Zlotnik ◽  
Michal Yackobovitch-Gavan ◽  
Moshe Phillip ◽  
Shlomit Shalitin

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 941-P
Author(s):  
LEI ZHANG ◽  
YAN GU ◽  
YUXIU YANG ◽  
NA WANG ◽  
WEIGUO GAO ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
pp. e001413
Author(s):  
Jonathan Yap ◽  
Kamalesh Anbalakan ◽  
Wan Ting Tay ◽  
Daniel Ting ◽  
Carol Yim Cheung ◽  
...  

IntroductionDiabetes mellitus is a growing public health epidemic in Asia. We examined the impact of type 2 diabetes, glycemic control and microvascular complications on mortality and cardiovascular outcomes in a multiethnic population-based cohort of Asians without prior cardiovascular disease.Research design and methodsThis was a prospective population-based cohort study in Singapore comprising participants from the three major Asian ethnic groups: Chinese, Malays and Indians, with baseline examination in 2004–2011. Participants with type 1 diabetes and those with cardiovascular disease at baseline were excluded. Type 2 diabetes, Hemoglobin A1c (HbA1c) levels and presence of microvascular complications (diabetic retinopathy and nephropathy) were defined at baseline. The primary outcome was all-cause mortality and major adverse cardiovascular events (MACEs), defined as a composite of cardiovascular mortality, myocardial infarction, stroke and revascularization, collected using a national registry.ResultsA total of 8541 subjects were included, of which 1890 had type 2 diabetes at baseline. Subjects were followed for a median of 6.4 (IQR 4.8–8.8) years. Diabetes was a significant predictor of mortality (adjusted HR 1.74, 95% CI 1.45 to 2.08, p<0.001) and MACE (adjusted HR 1.64, 95% CI 1.39 to 1.93, p<0.001). In those with diabetes, higher HbA1c levels were associated with increased MACE rates (adjusted HR (per 1% increase) 1.18, 95% CI 1.11 to 1.26, p<0.001) but not mortality (p=0.115). Subjects with two microvascular complications had significantly higher mortality and MACE compared with those with only either microvascular complication (adjusted p<0.05) and no microvascular complication (adjusted p<0.05).ConclusionDiabetes is a significant predictor of mortality and cardiovascular morbidity in Asian patients without prior cardiovascular disease. Among patients with type 2 diabetes, poorer glycemic control was associated with increased MACE but not mortality rates. Greater burden of microvascular complications identified a subset of patients with poorer outcomes.


Sign in / Sign up

Export Citation Format

Share Document